Figure 2 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 3 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 4 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

“…Data show means ± SEM. <i>n</i> values are the numbers of biological replicates in <i>in vitro</i> experiments.…”

Figure 6 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Toxicity of cellosolves and cellosolve acetate on <i>C. elegans</i> locomotion. by Masahiro Tomioka (430683)

Fig 5 - by Björn Jörges (9258411)

DDX5 and DDX17 decrease viral gene expression and virion production during KSHV lytic reactivation. by Praneet Kaur Sandhu (21156149)

Figure 7 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

“…Cytotoxicity was determined after 16 hours and normalized to Nalm6 cells without CAR T cells. Shown are data from one donor (<i>n</i> = 2). <b>E,</b> PD-L1 CAR T-cell cytotoxicity against luciferase-expressing PD-L1 knockout or PD-L1⁺ MDA-MB-231 cells in the presence of different concentrations of NH₄Cl. …”

Figure 5 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

“…Representative blot from one donor is shown. <b>B,</b> The concentration of extracellular perforin secreted by NK cells in response to contact with target cells (K562) in different concentrations of NH₄Cl (<i>n</i> = 4). …”

Serum concentrations of malondialdehyde (a) and super oxide dismutase (b) and NOx (nitrate +nitrite) (c) in different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

Treatment of cancer cells with vitamin D3 induced death <i>a.</i> by Vidya G. Bettada (22208808)

Decreased expression of tight junction proteins and disruption of intestinal barrier integrity in DSS-induced colitis mouse model. by Mariam Wed Eladham (21439745)

HSF2 reduced the decrease in the MMP in Caco-2 cells, which were observed by laser confocal microscopy. by Wen Wang (6570)

“…Red fluorescence indicated that there was no obvious abnormality in the MMP, while green fluorescence represented a decrease in the MMP. B: Statistical bar chart of the ratio of red to green fluorescence, <i>P</i> value of less than 0.05 was identified as* and <i>P</i> value of less than 0.01 was identified as**. …”

The comparison of the Spectral Exponent in hemispherotomy with a reference pediatric sample across wakefulness and NREM Sleep reveal values compatible with deep sleep in the isolat... by Michele Angelo Colombo (22446342)

Table 2_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

“…</p>Aims<p>This study aims to investigate the efficacy and safety of bridging hyper-fractionated radiotherapy in combination with CAR-T therapy for relapsed/refractory diffuse large B-cell lymphoma. The potential mechanisms were explored.…”

Table 1_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

“…</p>Aims<p>This study aims to investigate the efficacy and safety of bridging hyper-fractionated radiotherapy in combination with CAR-T therapy for relapsed/refractory diffuse large B-cell lymphoma. The potential mechanisms were explored.…”

Table 3_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

“…</p>Aims<p>This study aims to investigate the efficacy and safety of bridging hyper-fractionated radiotherapy in combination with CAR-T therapy for relapsed/refractory diffuse large B-cell lymphoma. The potential mechanisms were explored.…”

Data Sheet 1_Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center.docx by Ahmed Alsafar (21716735)

“…Background<p>Disparities in cancer outcomes persist between racial, ethnic, and socioeconomic groups. One potential cause is lack of appropriate representation in dose-finding clinical trials. …”

Comparison of social determinants of health (SDH) between hot and cold spots. Except for sewerage coverage and physician density, medians and interquartile ranges are presented. Ab... by Andrés Fernando Vinueza-Veloz (21681409)

Schematic presentation <i>M</i>. <i>bovis</i> PG45 5′ nucleotidase and phylogenetic tree of its homologs. by Aga E. Gelgie (17661720)